Uncovering the impact of noncoding variants in neurodegenerative brain diseases

Trends Genet. 2022 Mar;38(3):258-272. doi: 10.1016/j.tig.2021.08.010. Epub 2021 Sep 14.

Abstract

Neurodegenerative brain diseases (NBDs) are characterized by cognitive decline and movement impairments caused by neuronal loss in different brain regions. A large fraction of the genetic heritability of NBDs is not explained by the current known mutations. Genome-wide association studies identified novel disease-risk loci, adding to the genetic basis of NBDs. Many of the associated variants reside in noncoding regions with distinct molecular functions. Genetic variation in these regions can alter functions and contribute to disease pathogenesis. Here, we discuss noncoding variants associated with NBDs. Methods for better functional interpretation of noncoding variation will expand our knowledge of the genetic architecture of NBDs and broaden the routes for therapeutic strategies.

Keywords: dementia; genetic variants; genome-wide association studies (GWAS); neurodegeneration; noncoding DNA.

Publication types

  • Review

MeSH terms

  • Brain / pathology
  • Brain Diseases* / genetics
  • Brain Diseases* / pathology
  • Genetic Predisposition to Disease
  • Genetic Variation / genetics
  • Genome-Wide Association Study
  • Humans
  • Neurodegenerative Diseases* / genetics
  • Neurodegenerative Diseases* / pathology
  • Polymorphism, Single Nucleotide